Related Experiment Video
Updated: Sep 27, 2026
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
[Combined therapy for 121 cases of advanced cancer of the maxillary sinus]
Objective:
To investigate the possibility of combined therapy (chemotherapy + surgery) for advanced cancer of maxillary sinus.
Method:
Pre-operative radiation + surgery for 61 cases and preoperative chemotherapy + operation for 60 cases were performed. Radiotherapy referred to the use of linear accelerator and/or 60 Co with the dosage of 40-60 Gy. Chemotherapy referred to the administration of CDDP. VCR, and pingyangmycin.
Result:
The survival rate observed in the 61 cases treated with radiation operation was 36.1%; while the other 60 cases treated by chemotherapy + operation had a survival rate of 31.1%.
Conclusion:
The better way to treat advanced cancer of the maxillary sinus is pre-operative chemotherapy + surgery. In addition, repeated application of chemotherapy can raise the effect of surgical treatment.